Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Pricing Sign in

Hillstream BioPharma, Inc. HILS

Full chart Compare
Set alert

Price alert · HILS

All alert types
0.24 +0.24

Day range unavailable

52-week range unavailable

Financial health

Altman Z-Score

-0.55 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.2×
FY 2019: -34.8×FY 2020: -16.6×FY 2021: -11.6×FY 2022: -0.5×FY 2023: -0.0×FY 2024: -0.0×FY 2025: -0.2×
FY 2019 5y median -0.2× FY 2025
P/S 0.0×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2019 5y median 0.0× FY 2025
P/B 0.0×
FY 2019: -24.1×FY 2020: -10.5×FY 2021: -7.6×FY 2022: 0.8×FY 2023: 0.0×FY 2024: 0.2×FY 2025: 0.0×
FY 2019 5y median 0.0× FY 2025
P/FCF -0.4×
FY 2019: -55.4×FY 2020: -36.2×FY 2021: -33.0×FY 2022: -0.7×FY 2023: -0.0×FY 2024: -0.0×FY 2025: -0.4×
FY 2019 5y median -0.4× FY 2025
EV/EBITDA -452×
FY 2019: -39.2×FY 2020: -18.8×FY 2021: 83.1×FY 2022: 0.3×FY 2023: 1.1×FY 2024: 0.3×FY 2025: -452×
FY 2019 5y median 0.3× FY 2025
EV/Sales 0.0×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -278.0%
FY 2019: -1.8%FY 2020: -2.8%FY 2021: -3.0%FY 2022: -149.7%FY 2023: -3089.5%FY 2024: -4646.5%FY 2025: -278.0%
FY 2019 5y median -278.0% FY 2025

Profitability

Gross Margin 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
ROE -9.0%
FY 2019: 72.2%FY 2020: 63.9%FY 2021: 64.8%FY 2022: -152.8%FY 2023: -102.1%FY 2024: -932.8%FY 2025: -9.0%
FY 2019 5y median -102.1% FY 2025
ROIC -3.3%
FY 2019: 165.9%FY 2020: 95.1%FY 2021: 127.3%FY 2022: -124.1%FY 2023: -103.5%FY 2024: -950.9%FY 2025: -3.3%
FY 2019 5y median -103.5% FY 2025
ROA -6.9%
FY 2019: -2864.8%FY 2020: -805.5%FY 2021: -488.7%FY 2022: -126.7%FY 2023: -85.1%FY 2024: -327.7%FY 2025: -6.9%
FY 2019 5y median -126.7% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 FY 2025
Operating Income -61.7%
FY 2019: 0.0%FY 2020: -27.0%FY 2021: -77.4%FY 2022: -114.5%FY 2023: -37.4%FY 2024: -31.5%FY 2025: -61.7%
FY 2019 FY 2025
EPS (diluted) 88.1%
FY 2019: 0.0%FY 2020: -110.0%FY 2021: -42.9%FY 2022: -150.0%FY 2023: -852.0%FY 2024: -31.8%FY 2025: 88.1%
FY 2019 FY 2025
Free Cash Flow -47.9%
FY 2019: 0.0%FY 2020: -52.7%FY 2021: -0.7%FY 2022: -503.7%FY 2023: -11.3%FY 2024: -49.3%FY 2025: -47.9%
FY 2019 FY 2025

Financial Health

Current Ratio 5.3×
FY 2019: 0.0×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 5.8×FY 2023: 6.0×FY 2024: 1.5×FY 2025: 5.3×
FY 2019 5y median 5.3× FY 2025
Quick Ratio 5.3×
FY 2019: 0.0×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 5.8×FY 2023: 6.0×FY 2024: 1.5×FY 2025: 5.3×
FY 2019 5y median 5.3× FY 2025
Debt / Equity 0.0×
FY 2019: -0.6×FY 2020: -0.5×FY 2021: -0.5×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA -686×
FY 2019: -0.9×FY 2020: -0.8×FY 2021: 4.7×FY 2022: 0.9×FY 2023: 1.2×FY 2024: 0.3×FY 2025: -686×
FY 2019 5y median 0.9× FY 2025
Interest Coverage 709×
FY 2019: -19.0×FY 2020: -7.3×FY 2021: -3.9×FY 2022: -4.3×FY 2023: 573×FY 2024: 909×FY 2025: 709×
FY 2019 5y median 573× FY 2025

Dividends

Dividend Yield 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31